JENNAYA DAVIS: Open Payments
NPI 1134736135 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 65 payments from 19 companies in 2025. Trend: 2023 $1,659 · 2024 $934 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $216 |
| Sumitomo Pharma America, Inc. | 14 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $129 |
| UROGEN PHARMA, INC. | 3 | $73 |
| ABBVIE INC. | 4 | $73 |
| Dendreon Pharmaceuticals LLC | 3 | $71 |
| Janssen Biotech, Inc. | 4 | $65 |
| TOLMAR, INC. | 3 | $58 |
| IMMUNITYBIO, INC. | 2 | $50 |
Products named: KEYTRUDA, Nubeqa, PLUVICTO, GEMTESA, ORGOVYX, LYNPARZA, JELMYTO, BOTOX.
Industry payments across NC — which companies pay providers there.
